Research ArticleOpen AccessGoogle Scholar indexed
Botox: The Deadly Beauty
Faculty of Medicine & Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
Faculty of Medicine & Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
Department of Physiology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Malaysia
Faculty of Medicine & Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
Faculty of Medicine & Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
Faculty of Medicine & Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
- 1 Faculty of Medicine & Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
- 2 Department of Physiology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Malaysia
Forensic Medicine and Anatomy Research·Volume 07, Issue 1·Pages 13–17·Published 2 January 2019·DOI10.4236/fmar.2019.71003
Download PDF
Copy link · social · email
Abstract
Botox injection is the best known as a group of medication that uses various forms of Botulinum toxin A to temporarily paralyze muscle. It primarily reduces the appearance of some facial wrinkles and it is known as Botox Cosmetic. It is a popular treatment among people who want to achieve younger look. A 34-year-old female collapsed at beauty salon soon after receiving Botox injection. Although resuscitation was done in the emergency unit, hospital, she could not be revived and succumbed to death. This case report highlights the rare case of sudden death after Botox injection. We would like people to raise the awareness of unexpected occurrence after Botox injection while they make themselves beautify.
KeywordsBotulinum ToxinSudden DeathBotox Injection
- Kukreja, R. and Singh, B.R. (2009) Botulinum Neurotoxins: Structure and Mechanism of Action. Microbial Toxins: Current Research and Future Trends. Caister Academic Press.
- Food and Drug Administration. How Drugs Are Developed and Approved. https://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/
- Irvine, CA. (2012) BOTOX Cosmetic Product Information: BOTOX Cosmetic (onabotulinumtoxinA). http://www.allergan.com/products/medical_aesthetics/botox_cosmetic.htm
- Lorne, K.R., Kristen, A.T. and Grace, S. (2014) The First Case Report of a Systemic Allergy to OnabotulinumtoxinA (Botox) in a Healthy Patient. Aesthetic Surgery Journal, 34, 766-768.
- Li, M., Goldberger, B.A. and Hopkins, C. (2005) Fatal Case of BOTOX-Related Anaphylaxis? Journal of Forensic Sciences, 50, 169-172. https://doi.org/10.1520/JFS2004196
- Robert, A.H. (2017) FDA Approves Botox to Treat Chronic Migraines: BOTOX (R) Injections in Plastic Surgery WebMD.
- Khoklov, V.D., Krut, M.I. and Shashko, S. (2012) Anaphylactic Shock Following Administration of Lidocaine after Negative Skin Test. Klin Med (Mosk), 90, 62-64. (In Russian)
- Coté, T.R., Mohan, A.K., Polder, J.A., Walton, M.K. and Braun, M.M. (2005) Botulinum Toxin Type A Injections: Adverse Events Reported to the US Food and Drug Administration in Therapeutic and Cosmetic Cases. Journal of the American Academy of Dermatology, 53, 407-415. https://doi.org/10.1016/j.jaad.2005.06.011
- Daniel, S.C., Esther, T.T. and Susan, E. (2006) Botulism in 4 Adults Following Cosmetic Injections with an Unlicensed, Highly Concentrated Botulinum Preparation. JAMA, 296, 2476-2479. https://doi.org/10.1001/jama.296.20.2476